For years, the U.S. government tried to encourage deaf people to study science. But the programs were just ended by the Trump Administration, leaving deaf students unsure about their future.
The Trump administration defunded the National Institute of Health's MOSAIC grant program, which launched the careers of scientists from diverse backgrounds.
The unexpected elimination of funding for the decades-long research project focused on women's health shocked scientists. They were heartened by the quick restoration of support.
The new research will study the physical and mental health effects of gender transition. It comes on the heels of the administration cutting hundreds of research grants for LGBTQ+ health.
NPR obtained emails that went out last week to leaders at health agencies offering to transfer them to postings in tribal communities. Officials close to Dr. Anthony Fauci got the offer.
Some 2,000 scientists, including dozens of Nobel Prize winners, have signed an open letter warning that the U.S. lead in science is being "decimated" by the Trump administration's cuts to research.
Dr. Jay Bhattacharya, a Stanford professor of health policy, appears before the Senate HELP committee, which will vet his nomination to become the next director of the National Institutes of Health.
Dr. Francis Collins is leaving the National Institutes of Health, where he served as director from 2009 to 2021. The agency is facing cutbacks and restrictions under the Trump administration.
Iowa has the second highest incidence rate of cancer in the country, and it is already feeling Trump's cuts to the workforce and research institutions trying to solve the rural cancer problem.
Thousands of grant applications had been stalled when the Trump administration blocked the National Institutes of Health from posting notices to the Federal Register.
Researchers say the Trump administration's plan to slash payments for indirect costs will hamper new medical science. One example? A lab studying respiratory viruses faces losing half its staff.
The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer's and allergies.
Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth. Dr. Jay Bhattacharya, NIH nominee, will shed stock in Walmart and Nvidia.
